WATSON PHARMACEUTICALS INC·4

Jun 28, 12:18 PM ET

WATSON PHARMACEUTICALS INC 4

4 · WATSON PHARMACEUTICALS INC · Filed Jun 28, 2007

Insider Transaction Report

Form 4
Period: 2007-06-26
HSIA DAVID C
Sr. VP, Scientific Affairs
Transactions
  • Award

    Common Stock, par value $0.0033

    2007-06-26+4,00081,666 total
Holdings
  • Common Stock, par value $0.0033

    (indirect: By Trust)
    692,085
  • Common Stock, par value $0.0033

    (indirect: By Partnership)
    1,004,218
  • Common Stock, par value $0.0033

    (indirect: By Trust)
    40,000
Footnotes (4)
  • [F1]By Family Trust refers to the Hsia Family Trust, of which Dr. Hsia is a beneficial owner.
  • [F2]By Partnership refers to the Hsia Interests, Ltd., of which Dr. Hsia is a general partner.
  • [F3]The restricted stock was issued pursuant to the Second Amendment and Restatement of the 2001 Incentive Award Plan of Watson Pharmaceuticals, Inc. and will vest 50% on March 11, 2009 and 50% on March 11, 2011.
  • [F4]Includes shares of restricted stock issued pursuant to the Second Amendment and Restatement of the 2001 Incentive Award Plan of Watson Pharmaceuticals, Inc.

Documents

1 file
  • 4
    edgar.xmlPrimary

    FORM 4 -